Favorable, anti-inflammatory cytokines, such as IL-1RA, IL-7, and MIP-1β were detected in higher concentrations in responding patients, while pro-inflammatory, tumor-promoting cytokines, such as IL-18 and IL-1β, were higher in patients with early progressive disease. This evidence concerns the gene IL18 and neoplasm.